Article
Triphasic decline of hepatitis C virus RNA during antiviral therapy
27 Jun 2007
Abstract excerpt
UNLABELLED: When patients chronically infected with hepatitis C virus (HCV) are placed on antiviral therapy with pegylated interferon (IFN)-alpha or IFN-alpha plus ribavirin (RBV), HCV RNA generally declines in a biphasic manner. However, a triphasic decline has been reported in a subset of patients. A triphasic decline consists of a first phase (1-2 days) with rapid virus load decline, followed by a "shoulder...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
